SCHEMBL2189203

SCHEMBL2189203

CC(C)(C)OC(=O)c1cccc(NS(=O)(=O)c2cccnc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
TCF4 P15884 2/20 0.51
CTNNB1 P35222 2/20 0.51
GAA P10253 2/20 0.50
ALPL P05186 1/20 0.50
SNCA P37840 1/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
HIF1A Q16665 1/20 0.48
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
HTT P42858 1/20 0.47
NAMPT P43490 1/20 0.47
F2 P00734 1/20 0.46
TMPRSS6 Q8IU80 1/20 0.46
BRD4 O60885 1/20 0.46
STAT3 P40763 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17331317 0.84 SMN1; SMN2 (0.64) KMT2ATCF4CTNNB1HIF1AMAPT
SCHEMBL1676750 0.82 POLB (0.64) KMT2AGAASNCAMAPTSMN1; SMN2
SCHEMBL5720796 0.81 ABCG2 (0.55) KMT2AALPLHIF1AMAPTSMN1; SMN2
SCHEMBL17331338 0.81 NAMPT (0.54) KMT2AGAASNCAKEAP1NFE2L2
SCHEMBL17331308 0.77 KMT2A (0.50) KMT2AGAASNCAKEAP1NFE2L2
SCHEMBL17331320 0.76 SMN1; SMN2 (0.53) KMT2AGAASNCAMAPTSMN1; SMN2
SCHEMBL17331342 0.76 NAMPT (0.56) KMT2AGAASNCAMAPTSMN1; SMN2
SCHEMBL30872970 0.75 POLB (0.54) TCF4CTNNB1GAASMN1; SMN2ALDH1A1
SCHEMBL27183198 0.75 POLB (0.54) TCF4CTNNB1GAASMN1; SMN2ALDH1A1
SCHEMBL6436568 0.75 PLG (0.56) KMT2ATCF4CTNNB1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342177-B1 NOVEL POTASSIUM CHANNEL BLOCKERS JAPAN TOBACCO INC (JP) 2017-02-15 EP disclosed
US-9447033-B2 Potassium channel blockers JAPAN TOBACCO INC. (JP) 2016-09-20 US disclosed
US-20150259282-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2015-09-17 US disclosed
US-9073834-B2 Potassium channel blockers XENTION LIMITED (GB) 2015-07-07 US disclosed
US-20140221337-A1 Potassium Channel Blockers XENTION LIMITED (GB) 2014-08-07 US disclosed
US-8673901-B2 Potassium channel blockers XENTION LIMITED (GB) 2014-03-18 US disclosed
EP-2342177-A1 NOVEL POTASSIUM CHANNEL BLOCKERS Xention Limited (GB) 2011-07-13 EP disclosed
US-20100087428-A1 Novel Potassium Channel Blockers XENTION LIMITED (GB) 2010-04-08 US disclosed
WO-2010023448-A1 NOVEL POTASSIUM CHANNEL BLOCKERS XENTION LIMITED (GB) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221337-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 KMT2A 386/4885TCF4 828/4885CTNNB1 2546/4885
US-20100087428-A1 Novel Potassium Channel Blockers HCN4, SCN2B, KCNH2 KMT2A 1511/4885TCF4 1712/4885CTNNB1 1572/4885
US-20150259282-A1 Potassium Channel Blockers KCNJ2, KCNH2, KCNB1 KMT2A 386/4885TCF4 828/4885CTNNB1 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.